SLNCF
Price
$1.20
Change
+$0.12 (+11.11%)
Updated
Jan 7 closing price
Capitalization
170.04M
Intraday BUY SELL Signals
SOLTF
Price
$5.71
Change
+$0.41 (+7.74%)
Updated
Jan 13 closing price
Capitalization
455.24M
Intraday BUY SELL Signals
Interact to see
Advertisement

SLNCF vs SOLTF

Header iconSLNCF vs SOLTF Comparison
Open Charts SLNCF vs SOLTFBanner chart's image
Silence Therapeutics
Price$1.20
Change+$0.12 (+11.11%)
Volume$960
Capitalization170.04M
Nxera Pharma
Price$5.71
Change+$0.41 (+7.74%)
Volume$500
Capitalization455.24M
SLNCF vs SOLTF Comparison Chart in %
SLNCF
Daily Signal:
Gain/Loss:
SOLTF
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
SLNCF vs. SOLTF commentary
Jan 16, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SLNCF is a Hold and SOLTF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 16, 2026
Stock price -- (SLNCF: $1.20 vs. SOLTF: $5.71)
Brand notoriety: SLNCF and SOLTF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: SLNCF: 166% vs. SOLTF: 82%
Market capitalization -- SLNCF: $170.04M vs. SOLTF: $455.24M
SLNCF [@Biotechnology] is valued at $170.04M. SOLTF’s [@Biotechnology] market capitalization is $455.24M. The market cap for tickers in the [@Biotechnology] industry ranges from $111.36B to $0. The average market capitalization across the [@Biotechnology] industry is $2.26B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SLNCF’s FA Score shows that 1 FA rating(s) are green whileSOLTF’s FA Score has 0 green FA rating(s).

  • SLNCF’s FA Score: 1 green, 4 red.
  • SOLTF’s FA Score: 0 green, 5 red.
According to our system of comparison, SLNCF is a better buy in the long-term than SOLTF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SLNCF’s TA Score shows that 4 TA indicator(s) are bullish while SOLTF’s TA Score has 5 bullish TA indicator(s).

  • SLNCF’s TA Score: 4 bullish, 4 bearish.
  • SOLTF’s TA Score: 5 bullish, 2 bearish.
According to our system of comparison, SOLTF is a better buy in the short-term than SLNCF.

Price Growth

SLNCF (@Biotechnology) experienced а 0.00% price change this week, while SOLTF (@Biotechnology) price change was +4.20% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.72%. For the same industry, the average monthly price growth was +2.38%, and the average quarterly price growth was +41.99%.

Industries' Descriptions

@Biotechnology (+0.72% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SOLTF($455M) has a higher market cap than SLNCF($170M). SOLTF YTD gains are higher at: 4.197 vs. SLNCF (-40.000). SOLTF has higher annual earnings (EBITDA): 854M vs. SLNCF (-81.06M). SOLTF has more cash in the bank: 33B vs. SLNCF (102M). SLNCF has less debt than SOLTF: SLNCF (182K) vs SOLTF (64.7B). SOLTF has higher revenues than SLNCF: SOLTF (31.2B) vs SLNCF (25.8M).
SLNCFSOLTFSLNCF / SOLTF
Capitalization170M455M37%
EBITDA-81.06M854M-9%
Gain YTD-40.0004.197-953%
P/E RatioN/AN/A-
Revenue25.8M31.2B0%
Total Cash102M33B0%
Total Debt182K64.7B0%
FUNDAMENTALS RATINGS
SLNCF vs SOLTF: Fundamental Ratings
SLNCF
SOLTF
OUTLOOK RATING
1..100
9426
VALUATION
overvalued / fair valued / undervalued
1..100
22
Undervalued
92
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9898
PRICE GROWTH RATING
1..100
9159
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SLNCF's Valuation (22) in the null industry is significantly better than the same rating for SOLTF (92). This means that SLNCF’s stock grew significantly faster than SOLTF’s over the last 12 months.

SLNCF's Profit vs Risk Rating (100) in the null industry is in the same range as SOLTF (100). This means that SLNCF’s stock grew similarly to SOLTF’s over the last 12 months.

SLNCF's SMR Rating (98) in the null industry is in the same range as SOLTF (98). This means that SLNCF’s stock grew similarly to SOLTF’s over the last 12 months.

SOLTF's Price Growth Rating (59) in the null industry is in the same range as SLNCF (91). This means that SOLTF’s stock grew similarly to SLNCF’s over the last 12 months.

SOLTF's P/E Growth Rating (100) in the null industry is in the same range as SLNCF (100). This means that SOLTF’s stock grew similarly to SLNCF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
SLNCFSOLTF
RSI
ODDS (%)
Bullish Trend 1 day ago
72%
Bullish Trend 1 day ago
50%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
63%
Bearish Trend 1 day ago
51%
Momentum
ODDS (%)
Bearish Trend 1 day ago
67%
Bullish Trend 1 day ago
53%
MACD
ODDS (%)
Bearish Trend 1 day ago
66%
Bullish Trend 1 day ago
48%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
54%
Bullish Trend 1 day ago
36%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
65%
Bullish Trend 1 day ago
35%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
71%
N/A
Aroon
ODDS (%)
Bullish Trend 1 day ago
65%
Bearish Trend 1 day ago
52%
View a ticker or compare two or three
Interact to see
Advertisement
SLNCF
Daily Signal:
Gain/Loss:
SOLTF
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
KGDIX35.190.32
+0.92%
DWS Global Small Cap Inst
RYFIX107.380.53
+0.50%
Rydex Financial Services Inv
OMSCX25.000.08
+0.32%
Invesco Main Street All Cap C
POICX10.160.03
+0.30%
Virtus Tactical Allocation C
FHKFX12.51N/A
N/A
Fidelity Series Emerging Markets

SLNCF and

Correlation & Price change

A.I.dvisor tells us that SLNCF and ENVB have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SLNCF and ENVB's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLNCF
1D Price
Change %
SLNCF100%
N/A
ENVB - SLNCF
29%
Poorly correlated
-1.69%
RNXT - SLNCF
24%
Poorly correlated
-2.83%
SOLTF - SLNCF
9%
Poorly correlated
N/A
PVCT - SLNCF
8%
Poorly correlated
-3.83%
PXXLF - SLNCF
8%
Poorly correlated
N/A
More

SOLTF and

Correlation & Price change

A.I.dvisor indicates that over the last year, SOLTF has been loosely correlated with BIESF. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if SOLTF jumps, then BIESF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SOLTF
1D Price
Change %
SOLTF100%
N/A
BIESF - SOLTF
35%
Loosely correlated
N/A
BSFAF - SOLTF
29%
Poorly correlated
N/A
SPHRF - SOLTF
23%
Poorly correlated
N/A
SLNCF - SOLTF
9%
Poorly correlated
N/A
SPHDF - SOLTF
5%
Poorly correlated
N/A
More